Literature DB >> 7487216

Laparoscopic aortofemoral bypass. Initial experience in an animal model.

S S Ahn1, M F Clem, B D Braithwaite, B Concepcion, P V Petrik, W S Moore.   

Abstract

OBJECTIVE: The study objective was to evaluate the feasibility of laparoscopic aortofemoral bypass in a porcine model. SUMMARY BACKGROUND DATA: Laparoscopic techniques have been applied to numerous general and thoracic surgical procedures. Their application to vascular surgery has been virtually nonexistent. Open surgery for aortoiliac occlusive disease is accompanied by significant morbidity rates, and minimally invasive procedures have the disadvantage of reduced patency rates. Laparoscopic aortofemoral replacement has the theoretical advantage of long-term patency with reduced postoperative complications.
METHODS: Between January and September 1993, laparoscopic surgery was performed on 16 pigs: 6 underwent transperitoneal laparoscopic aortic dissection and vessel control alone; 7 underwent complete transperitoneal laparoscopic aortofemoral bypass; and 3 underwent a retroperitoneal approach. The aortic anastomosis was performed using a combination of sutures and titanium clips in an end-to-side fashion in five pigs, and a custom-made nonsutured graft was secured with use of an end-to-end method in five pigs. Femoral anastomoses were performed with the standard open technique.
RESULTS: Technical success was achieved in all 10 animals and with no major complications. Mean blood loss was 20 ml (range, 5-50 ml), and mean operative time was 2.45 hours (range, 2-4 hrs). On aortic-clamp release, 2 of the end-to-side anastomoses required additional sutures to stop bleeding between oversized staples, and 2 of the end-to-end anastomoses required additional ties to reinforce loose ties. All 10 grafts and anastomoses were patent and free of leaks after completion of the procedure.
CONCLUSIONS: Laparoscopic aortofemoral bypass is technically feasible in a porcine model. Further experimental work with new instrumentation and technical refinement will make laparoscopic surgery feasible for the treatment of vascular disease in humans.

Entities:  

Mesh:

Year:  1995        PMID: 7487216      PMCID: PMC1234996          DOI: 10.1097/00000658-199511000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  9 in total

1.  Factors that influence the outcome of aortoiliac and femoropopliteal percutaneous transluminal angioplasty.

Authors:  K W Johnston
Journal:  Surg Clin North Am       Date:  1992-08       Impact factor: 2.741

2.  Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial.

Authors:  J C Palmaz; J C Laborde; F J Rivera; C E Encarnacion; J D Lutz; J G Moss
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

3.  Proximal anastomosis in aortobifemoral bypass: end-to-end or end-to-side?

Authors:  D Mellière; J Labastie; J P Becquemin; M Kassab; E Paris
Journal:  J Cardiovasc Surg (Torino)       Date:  1990 Jan-Feb       Impact factor: 1.888

Review 4.  Aortobifemoral bypass--an enduring operation.

Authors:  F M Ameli
Journal:  Can J Surg       Date:  1992-06       Impact factor: 2.089

5.  Femorofemoral versus aortobifemoral bypass: outcome and hemodynamic results.

Authors:  J R Schneider; S R Besso; D B Walsh; R M Zwolak; J L Cronenwett
Journal:  J Vasc Surg       Date:  1994-01       Impact factor: 4.268

6.  Laparoscopic ligation of splenic artery aneurysm.

Authors:  M Hashizume; M Ohta; K Ueno; K Okadome; K Sugimachi
Journal:  Surgery       Date:  1993-03       Impact factor: 3.982

7.  Laparoscopy-assisted aortobifemoral bypass.

Authors:  Y M Dion; N Katkhouda; C Rouleau; A Aucoin
Journal:  Surg Laparosc Endosc       Date:  1993-10

8.  Predictors of surgical outcome in patients undergoing aortobifemoral bypass reconstruction.

Authors:  F M Ameli; M Stein; J L Provan; L Aro; R Prosser
Journal:  J Cardiovasc Surg (Torino)       Date:  1990 May-Jun       Impact factor: 1.888

9.  Laparoscopic resection of a splenic artery aneurysm.

Authors:  E C Saw; W Ku; S Ramachandra
Journal:  J Laparoendosc Surg       Date:  1993-04
  9 in total
  9 in total

1.  Minimally invasive surgery and the vascular specialist.

Authors:  Y M Dion; C Gracia
Journal:  Surg Endosc       Date:  1999-08       Impact factor: 4.584

2.  Newly designed retraction devices for intestine control during laparoscopic aortic surgery: a comparative study in an animal model.

Authors:  L Barbera; R Ludemann; M Grossefeld; L Welch; A Mumme; L Swanstrom
Journal:  Surg Endosc       Date:  2000-01       Impact factor: 4.584

3.  Endoscopic approach for carotid artery surgery.

Authors:  F Rubino; R Nahouraii; H Deutsch; W King; W B Inabnet; M Gagner
Journal:  Surg Endosc       Date:  2002-02-28       Impact factor: 4.584

4.  Laparoscopic aortofemoral bypass in an animal model.

Authors:  J Byrne; J W Hallett
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

5.  Transperitoneal and retroperitoneal laparoscopic implantation of an aortofemoral prosthesis.

Authors:  S Said
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

6.  Laparoscopic aortofemoral bypass surgery performed in an animal model.

Authors:  G Weber
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

7.  Intestinal retractor for transperitoneal laparoscopic aortoiliac reconstruction: experimental study on human cadavers and initial clinical experience.

Authors:  Y S Alimi; O Hartung; C Cavalero; C Brunet; J Bonnoit; C Juhan
Journal:  Surg Endosc       Date:  2000-10       Impact factor: 4.584

8.  Performance measurements in endolaparoscopic infrarenal aortic graft implantation using computer-enhanced instrumentation: a laboratory model for training.

Authors:  Bernardo D Martinez; Catherine S Wiegand; Jose Mendez
Journal:  JSLS       Date:  2007 Jul-Sep       Impact factor: 2.172

9.  A porcine model for endolaparoscopic abdominal aortic repair and endoscopic training.

Authors:  Bernardo D Martinez; Christopher K Zarins; David A Daunt; Leslie A Coleman; Yamil Saenz; Thomas J Fogarty; George D Hermann; Camran R Nezhat; Eric K Olsen
Journal:  JSLS       Date:  2003 Apr-Jun       Impact factor: 2.172

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.